Back to Agenda
Impact of Human Factors on the Development of Combination Products
Session Chair(s)
Muriel Didier
Human Factors Group Head, Novartis, Switzerland
Impact of Human Factors on the Development of Combination Products
Speaker(s)
Panel Discussion
Chin-Wei Soo, DRSc
Global Regulatory Head, PTR Devices and Combination Products, Genentech, A Member of the Roche Group, United States
Panel Discussion
Lee Wood, MSc
Co-Founder and CEO, MedHF, Switzerland
Panel Discussion
Andrew Warrington
, DayOneLab, Switzerland
Panel Discussion
Edward James Oakeley, PhD
Patient Advocate, Patient Advocate, Switzerland
Have an account?